MAM
Rajeev Khanna is Abu Dhabi T10 COO
MUMBAI: The cricket league Abu Dhabi T10 announces the appointment of Rajeev Khanna as COO for the upcoming season of the tournament, wherein he will be responsible for the overall management and the competition’s operations.
Khanna, who is a former cricket player, has been a pioneer in the field of sports management. He has converted his passion for sports into a career with tenures at leagues such as the Indian Premier League (IPL), Pro Kabaddi League and International Tennis Premier League.
Khanna has been working in the IPL since 2009. He has served as Punjab Kings, COO at Rajasthan Royals, VP at Rajasthan Royals and currently as a consultant for Rajasthan Royals. Through the years, he has been able to bring about a phenomenal change in the ways of sports management at the highest stage.
Khanna said, “The Abu Dhabi T10 is the most exhilarating cricket tournament in the world and therefore, I am very excited to join the bandwagon as the COO of the competition. I will definitely look to ensure that the legacy of the tournament continues to grow exponentially and becomes an even bigger attraction for the stars of the game in the future.”
T10 Sports Management chairman Shaji Ul Mulk said, “Rajeev Khanna has achieved great heights during his career and we are very excited to welcome him to the Abu Dhabi T10 family. I am sure that our tournament will benefit hugely from his experience, and we look forward to a long and fruitful relationship with him.”
The Abu Dhabi T10 will be played at the Zayed Cricket Stadium in Abu Dhabi from 23 November – 4 December 2022.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
